医学
非酒精性脂肪肝
脂肪变性
脂肪性肝炎
纤维化
非酒精性脂肪性肝炎
病态的
慢性肝病
肝病
病理生理学
脂肪肝
内科学
疾病
生物信息学
胃肠病学
肝硬化
生物
作者
Qing‐Jiang Pan,Jian‐Gao Fan,Yusuf Yılmaz
标识
DOI:10.1016/j.cld.2023.01.013
摘要
Nonalcoholic fatty liver disease (NAFLD)-a condition of excess fat accumulation in hepatocytes associated with metabolic dysfunction-has surpassed viral hepatitis to become the most prevalent chronic liver disease worldwide. As of now, only modestly effective pharmacological therapies for NAFLD exist. The uncomplete understanding of the pathophysiology underlying the heterogeneous disease spectrum known as NAFLD remains one of the major obstacles to the development of novel therapeutic approaches. This review compiles current knowledge on the principal signaling pathways and pathogenic mechanisms involved in NAFLD, which are analyzed in relation to its main pathological hallmarks (ie, hepatic steatosis, steatohepatitis, and liver fibrosis).
科研通智能强力驱动
Strongly Powered by AbleSci AI